Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19

In the development of new vaccines, many trials use age de-escalation: after establishing safety and efficacy in adult populations, progressively younger cohorts are enrolled and studied. Age de-escalation promotes many values. The responsibility to protect children from potential risks of experimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbin, Ami, Laventhal, Naomi, Navin, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888531/
https://www.ncbi.nlm.nih.gov/pubmed/36732168
http://dx.doi.org/10.1016/j.vaccine.2023.01.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888531/
https://www.ncbi.nlm.nih.gov/pubmed/36732168
http://dx.doi.org/10.1016/j.vaccine.2023.01.055

Ejemplares similares